Sign Out
Allora 5: Renal or hepatic impairment.
Allora Syrup: Liver dysfunction (desloratadine is metabolized in liver; potential for enhanced toxicity and need for dose adjustment).
Dose adjustment recommended in renal impairment.
Desloratadine should be administered with caution in patients with a medical or family history of seizures. In particular, young children may be more susceptible to developing new seizures under desloratadine treatment. Healthcare providers may consider discontinuing desloratadine in patients who experience a seizure while on treatment.
Use in Children: Allora Syrup: Safety and efficacy have not been established in children less than 6 months of age.
Continue with Google